PL-12 acquired hemophilia in malignancy

Thrombosis Research

Volumn 129, Issue SUPPL. 1, 2012, Pages

  Reeves, Brandi N ^a   Key, Nigel S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Acquired hemofilia; Bypassing agent; Cancer; Factor VIII; Hemorrhage

Indexed keywords

BLOOD CLOTTING FACTOR 8 INHIBITOR; DESMOPRESSIN; IMMUNOSUPPRESSIVE AGENT;

CONFERENCE PAPER; HEMATOLOGIC MALIGNANCY; HEMOPHILIA; HEMOSTASIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; SYSTEMATIC REVIEW; THROMBOSIS; ARTICLE; HEMOPHILIA A; NEOPLASM;

HEMOPHILIA A; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NEOPLASMS;

EID: 84862149270     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(12)70019-1     Document Type: Conference Paper

References (27)

1. RJ Belt, C Leite, CD Haas, RL Stephens Incidence of hemorrhagic complications in patients with cancer JAMA 239 1978 2571 2574 (Pubitemid 8393889)
2. EM Hersh, GP Bodey, BA Nies, EJ Freireich Causes of Death in Acute Leukemia: A Ten-Year Study of 414 Patients from 1954-1963 JAMA 193 1965 105 109
3. J Inagaki, V Rodriguez, GP Bodey Proceedings: Causes of death in cancer patients Cancer 33 1974 568 573
4. CR Hay Acquired haemophilia Baillieres Clin Haematol 11 1998 287 303 (Pubitemid 29103545)
5. M Franchini, G Targher, M Montagnana, G Lippi Laboratory, clinical and therapeutic aspects of acquired hemophilia A Clin Chim Acta 395 2008 14 18
6. RL Bitting, S Bent, Y Li, J Kohlwes The prognosis and treatment of acquired hemophilia: a systematic review and meta-analysis Blood Coagul Fibrinolysis 20 2009 517 523
7. MB Hultin Acquired inhibitors in malignant and nonmalignant disease states Am J Med 91 1991 9S 13S
8. S Shetty, P Kasatkar, K Ghosh Pathophysiology of acquired von Willebrand disease: a concise review Eur J Haematol 87 2011 99 106
9. PW Collins, S Hirsch, TP Baglin, G Dolan, J Hanley, M Makris et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation Blood 109 2007 1870 1877 (Pubitemid 46348182)
10. J Delgado, V Jimenez-Yuste, F Hernandez-Navarro, A Villar Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors Br J Haematol 121 2003 21 35 (Pubitemid 36461264)
11. D Green, K Lechner A survey of 215 non-hemophilic patients with inhibitors to Factor VIII Thromb Haemost 45 1981 200 203 (Pubitemid 11081028)
12. I Hauser, K Lechner Solid tumors and factor VIII antibodies Thromb Haemost 82 1999 1005 1007 (Pubitemid 29419708)
13. S Sallah, JY Wan Inhibitors against factor VIII in patients with cancer. Analysis of 41 patients Cancer 91 2001 1067 1074 (Pubitemid 32295411)
14. S Reitter, P Knoebl, I Pabinger, K Lechner Postoperative paraneoplastic factor VIII auto-antibodies in patients with solid tumours Haemophilia 17 2011 e889 e894
15. M Algiman, G Dietrich, UE Nydegger, D Boieldieu, Y Sultan, MD Kazatchkine Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals Proc Natl Acad Sci U S A 89 1992 3795 3799
16. H Levesque, JY Borg, P Bossi, J Goudemand, B Guillet, J Cabane [Acquired hemophilia: current diagnostic and therapeutic approaches] Rev Med Intern 22 2001 854 866
17. R Lottenberg, TB Kentro, CS Kitchens Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy Arch Intern Med 147 1987 1077 1081 (Pubitemid 17113272)
18. Marco P CP, Knoebl P, Levesque H, Baudo F, Nemes L, Tengborn L, Huth-Kuehne A, Pellegrini F. 1398 Acquired Haemophilia: Clinical and Demographic Data. Results of European Acquired Haemophilia Registry (EACH2). 53rd ASH Annual Meeting and Exposition, 2010.
19. A Aouba, G Rey, G Pavillon, E Jougla, C Rothschild, MF Torchet et al. Deaths associated with acquired haemophilia in France from 2000 to 2009: multiple cause analysis for best care strategies Haemophilia 2011
20. A Huth-Kuhne, F Baudo, P Collins, J Ingerslev, CM Kessler, H Levesque et al. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A Haematologica 94 2009 566 575
21. CL Kempton, TC Abshire, RA Deveras, WK Hoots, JC Gill, CM Kessler et al. Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia A Haemophilia 2012
22. M Franchini, G Lippi The use of desmopressin in acquired haemophilia A: a systematic review Blood Transfus 9 2011 377 382
23. PBF Knoebl, PW Collins, A Huth-Kuehne, H Levesque, P Marco, L Nemes, F Pellegrini, L Tengborn Management of Bleeding in Acquired Hemophilia: Results of the European Acquired Hemophilia Registry (EACH2) Blood 2010 ASH Annual Meeting Abstracts:716.
24. S Sallah Treatment of acquired haemophilia with factor eight inhibitor bypassing activity Haemophilia 10 2004 169 173 (Pubitemid 38312644)
25. PW Collins, S Hirsch, TP Baglin, G Dolan, J Hanley, M Makris et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation Blood 109 2007 1870 1877 (Pubitemid 46348182)
26. JC Boles, NS Key, R Kasthuri, AD Ma Single-center experience with rituximab as first-line immunosuppression for acquired hemophilia J Thromb Haemost 9 2011 1429 1431
27. A Aouba, G Rey, G Pavillon, E Jougla, C Rothschild, MF Torchet et al. Deaths associated with acquired haemophilia in France from 2000 to 2009: multiple cause analysis for best care strategies Haemophilia 2011